Synthego's CRISPR platform enables faster ID of potential Coronavirus treatment
A collaboration between Synthego and The Krogan Lab used CRISPR-based genome engineering to study genes associated with SARS-CoV-2. This approach revealed key targets for potential coronavirus treatment, accelerating research in the fight against COVID-19.